Ventyx Biosciences Stock Market Value
| VTYX Stock | USD 2.65 0.11 4.33% |
| Symbol | Ventyx |
Ventyx Biosciences Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ventyx Biosciences. If investors know Ventyx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ventyx Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.35) | Return On Assets (0.33) | Return On Equity (0.54) |
The market value of Ventyx Biosciences is measured differently than its book value, which is the value of Ventyx that is recorded on the company's balance sheet. Investors also form their own opinion of Ventyx Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ventyx Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ventyx Biosciences' market value can be influenced by many factors that don't directly affect Ventyx Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ventyx Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ventyx Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ventyx Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Ventyx Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ventyx Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ventyx Biosciences.
| 06/01/2024 |
| 11/28/2024 |
If you would invest 0.00 in Ventyx Biosciences on June 1, 2024 and sell it all today you would earn a total of 0.00 from holding Ventyx Biosciences or generate 0.0% return on investment in Ventyx Biosciences over 180 days. Ventyx Biosciences is related to or competes with Arcellx, Immunocore Holdings, Vaxcyte, Nuvalent, Travere Therapeutics, Structure Therapeutics, and Replimune. Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to addr... More
Ventyx Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ventyx Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ventyx Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.42 | |||
| Information Ratio | 0.0536 | |||
| Maximum Drawdown | 16.88 | |||
| Value At Risk | (5.63) | |||
| Potential Upside | 6.96 |
Ventyx Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ventyx Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ventyx Biosciences' standard deviation. In reality, there are many statistical measures that can use Ventyx Biosciences historical prices to predict the future Ventyx Biosciences' volatility.| Risk Adjusted Performance | 0.0694 | |||
| Jensen Alpha | 0.0891 | |||
| Total Risk Alpha | (0.35) | |||
| Sortino Ratio | 0.0756 | |||
| Treynor Ratio | 0.1515 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ventyx Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ventyx Biosciences Backtested Returns
Ventyx Biosciences appears to be somewhat reliable, given 3 months investment horizon. Ventyx Biosciences owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.078, which indicates the firm had a 0.078% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Ventyx Biosciences, which you can use to evaluate the volatility of the company. Please review Ventyx Biosciences' Semi Deviation of 3.12, coefficient of variation of 1256.04, and Risk Adjusted Performance of 0.0694 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Ventyx Biosciences holds a performance score of 6. The entity has a beta of 2.47, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Ventyx Biosciences will likely underperform. Please check Ventyx Biosciences' expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether Ventyx Biosciences' existing price patterns will revert.
Auto-correlation | 0.14 |
Insignificant predictability
Ventyx Biosciences has insignificant predictability. Overlapping area represents the amount of predictability between Ventyx Biosciences time series from 1st of June 2024 to 30th of August 2024 and 30th of August 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ventyx Biosciences price movement. The serial correlation of 0.14 indicates that less than 14.0% of current Ventyx Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.14 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Ventyx Biosciences lagged returns against current returns
Autocorrelation, which is Ventyx Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ventyx Biosciences' stock expected returns. We can calculate the autocorrelation of Ventyx Biosciences returns to help us make a trade decision. For example, suppose you find that Ventyx Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ventyx Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ventyx Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ventyx Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ventyx Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Ventyx Biosciences Lagged Returns
When evaluating Ventyx Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ventyx Biosciences stock have on its future price. Ventyx Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ventyx Biosciences autocorrelation shows the relationship between Ventyx Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Ventyx Biosciences.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Ventyx Stock Analysis
When running Ventyx Biosciences' price analysis, check to measure Ventyx Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventyx Biosciences is operating at the current time. Most of Ventyx Biosciences' value examination focuses on studying past and present price action to predict the probability of Ventyx Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventyx Biosciences' price. Additionally, you may evaluate how the addition of Ventyx Biosciences to your portfolios can decrease your overall portfolio volatility.